Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Evaluator and Subject-blinded, Randomized, Comparator-controlled, Parallel-design Study to Evaluate the Safety and Effectiveness of NOA VOLUME Compared to JUVÉDERM® VOLUMA® XC for Improvement of Mid-face Volume

NCT06734351 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06734351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06734351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Evaluator and Subject-blinded, Randomized, Comparator-controlled, Parallel-design Study to Evaluate the Safety and Effectiveness of NOA VOLUME Compared to JUVÉDERM® VOLUMA® XC for Improvement of Mid-face Volume
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Recruiting
Start date
December 16, 2024
Completion date
July 31, 2029
Enrollment
231 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

mid face volume deficit